Episode Details
Back to Episodes323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Published 2 years, 1 month ago
Description
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."